BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Zhang T, Nie Y, Gu J, Cai K, Chen X, Li H, Wang J. Identification of Mitochondrial-Related Prognostic Biomarkers Associated With Primary Bile Acid Biosynthesis and Tumor Microenvironment of Hepatocellular Carcinoma. Front Oncol 2021;11:587479. [PMID: 33868990 DOI: 10.3389/fonc.2021.587479] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Bai Y, Cao K, Zhang P, Ma J, Zhu J. Prognostic and Immunological Implications of FAM72A in Pan-Cancer and Functional Validations. Int J Mol Sci 2022;24. [PMID: 36613817 DOI: 10.3390/ijms24010375] [Reference Citation Analysis]
2 Zhou Q, Chen L, Yang L, Zhou H, Chen Y, Guo Y. Integrated systemic analysis of FAM72A to identify its clinical relevance, biological function, and relationship to drug sensitivity in hepatocellular carcinoma. Front Oncol 2022;12. [DOI: 10.3389/fonc.2022.1046473] [Reference Citation Analysis]
3 Xing L, Zeng R, Huang K, Xue J, Liu H, Zhao Z, Peng Y, Hu X, Liu C. Fuzheng Huayu Recipe and its active compounds inhibited HBeAg production by promoting TOMM34 gene expression in HBV-infected hepatocytes. Front Pharmacol 2022;13:907921. [DOI: 10.3389/fphar.2022.907921] [Reference Citation Analysis]
4 Yu H, Yu M, Li Z, Zhang E, Ma H. Identification and analysis of mitochondria-related key genes of heart failure. J Transl Med 2022;20:410. [PMID: 36071497 DOI: 10.1186/s12967-022-03605-2] [Reference Citation Analysis]
5 Vujovic A, de Rooij LP, Chahi AK, Chen HT, Yee B, Loganathan SK, Liu L, Chan DC, Tajik A, Tsao E, Moreira S, Joshi P, Xu J, Wong N, Zandi S, Aigner S, Dick JE, Minden MD, Schramek D, Yeo GW, Hope KJ. A two-step in vivo CRISPR screen unveils pervasive RNA binding protein dependencies for leukemic stem cells and identifies ELAVL1 as a therapeutic target.. [DOI: 10.1101/2022.06.11.494613] [Reference Citation Analysis]
6 Yang Y, Li J, Tang M, Nie B, Huang W. Decaprenyl Diphosphate Synthase Subunit 1 (PDSS1): A Potential Prognostic Biomarker and Immunotherapy-Target for Hepatocellular Carcinoma. CMAR 2022;Volume 14:1627-39. [DOI: 10.2147/cmar.s364346] [Reference Citation Analysis]
7 Wang Y, Song F, Zhang X, Yang C, Zhang J. Mitochondrial-Related Transcriptome Feature Correlates with Prognosis, Vascular Invasion, Tumor Microenvironment, and Treatment Response in Hepatocellular Carcinoma. Oxidative Medicine and Cellular Longevity 2022;2022:1-28. [DOI: 10.1155/2022/1592905] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
8 Sun C, Ma S, Chen Y, Kim NH, Kailas S, Wang Y, Gu W, Chen Y, Tuason JPW, Bhan C, Manem N, Huang Y, Cheng C, Zhou Z, Zhou Q, Zhu Y. Diagnostic Value, Prognostic Value, and Immune Infiltration of LOX Family Members in Liver Cancer: Bioinformatic Analysis. Front Oncol 2022;12:843880. [DOI: 10.3389/fonc.2022.843880] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
9 Cheng W, Wang Y, Liu J, Li X, Yu M, Duan C, Liu L, Zhang J. Hepatotoxicity of cantharidin is associated with the altered bile acid metabolism. J Appl Toxicol 2021. [PMID: 34866203 DOI: 10.1002/jat.4267] [Reference Citation Analysis]
10 Renganathan S, Pramanik S, Ekambaram R, Kutzner A, Kim PS, Heese K. Identification of a Chemotherapeutic Lead Molecule for the Potential Disruption of the FAM72A-UNG2 Interaction to Interfere with Genome Stability, Centromere Formation, and Genome Editing. Cancers (Basel) 2021;13:5870. [PMID: 34831023 DOI: 10.3390/cancers13225870] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
11 Jiang X, Xia Y, Meng H, Liu Y, Cui J, Huang H, Yin G, Shi B. Identification of a Nuclear Mitochondrial-Related Multi-Genes Signature to Predict the Prognosis of Bladder Cancer. Front Oncol 2021;11:746029. [PMID: 34692528 DOI: 10.3389/fonc.2021.746029] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]